# A Clinical Trial for CTD-ILD Treatment

> **NCT01424033** · PHASE2,PHASE3 · TERMINATED · sponsor: **University of Michigan** · enrollment: 5 (actual)

## Conditions studied

- Interstitial Lung Disease
- Connective Tissue Disease

## Interventions

- **DRUG:** N-Acetylcysteine

## Key facts

- **NCT ID:** NCT01424033
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-12
- **Primary completion:** 2013-02
- **Final completion:** —
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Departure of study team
- **Last updated:** 2017-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01424033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01424033, "A Clinical Trial for CTD-ILD Treatment". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01424033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*